TRENDS OF MASS-ACTION LAW BASED THEORY COMPUSYN SOFTWARE, COMBOSYN, INC. PD SCIENCE LLC (USA)
|
|
- Madison Barber
- 6 years ago
- Views:
Transcription
1 TRENDS OF MASS-ACTION LAW BASED THEORY COMPUSYN SOFTWARE, COMBOSYN, INC. PD SCIENCE LLC (USA) The Mass-Action Law Based Theory & Theorems Digital Pharmacodynamics/ Biodynamics: Definitions & Applications Synergism Digital Definition & Quantification Algorithms/Computerized Auto-Simulation Small Size Design & Experimentation Definitive/Quantitative Biology Econo-Green Bio-Medical R & D Scientific Definitions and Claims for Regulatory Affairs Ting-Chao Chou, July 25, 2017
2 [News Release, March 16, 2016] Chou & Talalay Paper from 1984 Makes History One of the most cited papers Published in 1984, the manuscript Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors by Ting-Chao Chou and Paul Talalay has become one of most cited articles in all fields. With 3,520 citations, it is not only the most cited article in Advances in Biological Regulation, but also one of the most cited articles (being in the top 1% of most cited articles) in the field of Biochemistry, Cancer Research, Molecular Biology and Genetics (Scopus, 16 th March 2016). Here is what Ting-Chao Chou, first author of the manuscript tells us: Over 31 years ago, Prof. George Weber of Indiana University invited Prof. Paul Talalay (JHU) and me (MSKCC) to give a symposium talk sponsored by Eli Lilly, in conjunction with Advances in Enzyme Regulation. My talk was very much impressed by Professor Carl F. Cori of Harvard (Nobel Laureate of Medicine 1947). His vision has proven to be extremely insightful and accurate. The paper in Adv. Enz. Regul. 22:27-55, 1984 by Chou & Talalay has become among the most cited and the most broadly cited theoretical papers of all time in all fields. It is our pleasure to celebrate this milestone for our journal and for this occasion we have provided free promotional access to the article for 6 months on ScienceDirect.
3 Quantitative-Analysis of Dose-Effect Relationships- The Combined Effects of Multiple-Drugs or Enzyme-Inhibitors [The Combination Index Theorem] (As of ] CHOU, TC & TALALAY, P ADVANCES IN ENZYME REGULATION, 22: 27-55, 1984* Times Cited: 5,235; (4,112 Citations in 778 Journals) *Elsevier News Release: Chou & Talalay Article from 1984 Makes History ( )
4 4,112 Chou -Talalay CI Theory (1984)
5 Synergy Definition for Drug Combinations (Controversy for Over 100 Years) Drug Combination: Widely Used in Cancer, AIDS & Chinese Medicine Synergism: 20 Different Synergy Definitions None Supports the Others!! [A total mess in Basic Research, in Clinical Drug Combination trials (in Protocol Design & in Data Analysis) and in Governmental Regulations] Combination Index Theorem: Chou and Talalay, Equation & Algorithm CI <1, Synergism CI=1, Additive CI>1, Antagonism With Quantitative, Automated, Computerized Simulation Challenge: If No Clear Definition for Synergy: NIH, FDA, USPTO and Peer Reviewers have No Basis to Judge or to Regulate the Synergy Claims The Dispel of the Century-Old Controversy Chou TC Theory: Pharmacol. Rev. 58: , 2006 ( Review, 61-pages) (Cited 2,115 times by 538 journals) Adv. Enz. Regul. 22:27-55, 1984 (Created the CI theorem) (Cited 5,235 times by 778 journals) Cancer Res. 70: , 2010 (Perspectives) (Cited 1,453 times in 351 journals) 5
6 Ting-Chao Chou Google Scholar Citations [July 25, 2017]
7 Trends of Drug Combination Methods for Synergy Determination, June 2017* Thomson Reuters Web of Science Citation Database Method, and Reference Source Trend of Citation Total Citations Since Publication Average Citations per year A. Chou, TC & Talalay, P Adv. Eng. Regul. 1984; 22:27-55 [ME & CI Theory] , B. Chou, TC Pharmacol. Rev. 2006;58: [CI Review] , C. Chou TC Cancer Res. 2010; 70: [CI Perspectives] , D. Berenbaum, MC Pharmacol. Rev. 1989; 41: E. Bliss, CI Ann. Appl. Biol. 1939; 26: F. Greco, WR et al Pharamacol. Rev. 1995; 47: G. Steel GG & Peckham MJ Int. J. Radiant. Oncol. BioPhys. 1979; 5: H. Elion GB, Singer S & Hitchings GH J. Biol. Chem. 1954; 208: I. Tallarida, RJ J. Pharmacol. Exp. Ther. 2001; 298: J. Prichard, MN & Shipman C Jr Antiviral Res. 1990; 14: K. Webb J.L. Acad. Press. 1963; 1: 66-79, # 4.5 L. Loewe, S Pharmacol. Rev. 1957; 9: *Based on Thomson Reuters Web of Science Core Collection, as of June 10, (Citation numbers are higher in Google Scholar Citations). #Based on Google Scholar Citations, as of June 10, 2017.
8 Number of Cumulative Citations Time Course of Cumulative Citations of Chou TC & Talalay P Adv. Enz. Regul. 22: 27-55, 1984 (Thomson-Reuters Web of Science) Prof. Carl Cori (Nobel- 1947) asked for preprint. It received only 1 citation in 1 st year, 5 citations in 2 nd year. Now 33 years later, it received a total of 4,112 citations in 778 journals. [The 1 st 10 Years Received only 404 Citations] Elsevier News Release: March 16, 2016 Chou & Talalay Paper from 1984 Makes History. One of the most cited theoretical papers in all fields
9 Scopus Analysis: Chou TC s Publications Cited by Papers from Institutional Affiliations
10 T.C. Chou Web Sites Thomson-Reuters Web of Science: Google Search: Ting-Chao Chou Ting-Chao Chou - Google Scholar Citations Wikipedia: Ting-Chao Chou [For Free Download] For Philosophy:
11 11
PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH
PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH COMBINATION THERAPIES : Part II: Measuring Synergistic Effects BASIC QUESTION When both of the agents in a combination are active, that is to
More informationFaculty Development. Measures of Success and How to Attain Them
Measures of Success and How to Attain Them Kathy Griendling, PhD Professor of Medicine Vice Chair for Research and Faculty Development Assistant Dean for Faculty Development Why measure success? To fulfill
More informationJournal Impact Factors and the Author h-index: tools used for benchmarking the quality of research
Journal Impact Factors and the Author h-index: tools used for benchmarking the quality of research Katie Newman Biotechnology Librarian florador@illinois.edu -- 217-265-5386 2130 Institute for Genomic
More informationBIOSTATISTICAL METHODS
BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH Combination Chemotherapy: DESIGNING CLINICAL RESEARCH Use of a combination of two therapeutics, especially drug-drug combination (called combination
More informationScientific Publications in Pharmacology and Pharmacy Journals from Chinese Authors in Various Parts of North Asia: a 10-year Survey of the Literature
The Journal of International Medical Research 2010; 38: 750 759 [first published online as 38(3) 5] Scientific Publications in Pharmacology and Pharmacy Journals from Chinese Authors in Various Parts of
More informationMerging the Science of Quantitative Pharmacology into Routine Patient Care: Focus on Digital Tools
Merging the Science of Quantitative Pharmacology into Routine Patient Care: Focus on Digital Tools Janel Long-Boyle, PharmD, PhD Associate Professor of Clinical Pharmacy UCSF School of Pharmacy Disclosure(s)
More informationLA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES
LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES Francesca Pasinelli Direttore Generale 3 Congresso Nazionale SIFaCT Roma, 9 ottobre 2015 About Telethon Fondazione Telethon is
More informationPharmaceutical Informatics and the Pathway to Personalized Medicines
Pharmaceutical Informatics and the Pathway to Personalized Medicines Sangtae Kim and Venkat Venkatasubramanian Purdue University ICCS2007 DDDAS Workshop Beijing May 26-28, 2007 Outline The Grand Challenge
More informationGenomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)
Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome
More information1. Survey Framework on Knowledge Production Process
Survey-based approaches to measuring knowledge flows and use of knowledge exchange mechanisms, OECD-KNOWINNO workshop on Measuring the use and impact of Knowledge Exchange Mechanisms Measuring knowledge
More informationA Life-cycle Approach to Dose Finding Studies
A Life-cycle Approach to Dose Finding Studies Rajeshwari Sridhara, Ph.D. Director, Division of Biometrics V Center for Drug Evaluation and Research, USFDA This presentation reflects the views of the author
More informationUniversity of California Center for Accelerated Innovation
University of California Center for Accelerated Innovation MICHAEL PALAZZOLO April 6, 2015 Outline CAI overview and introduction RFA and important dates Selection process Pre-application Finding help 2
More informationCurrent Issues Regarding Data and Safety Monitoring Committees in Clinical Trials
Current Issues Regarding Data and Safety Monitoring Committees in Clinical Trials Discussion: Emerging Challenges in the Practice of Clinical Trial Data Monitoring Committees Maureen G. Maguire, PhD Carolyn
More informationJournal Of Molecular Medicine Authorship Statement
Journal Of Molecular Medicine Authorship Statement American Journal of Respiratory and Critical Care Medicine Care Units An Official American Thoracic Society Statement: The Importance of Healthy Sleep.
More informationREFLECTIONS ON THE H-INDEX
B&L Business & Leadership Nr. 1-2012, pp. 101-106 ISSN 2069-4814 EVALUATION OF ACADEMIC IMPACT REFLECTIONS ON THE H-INDEX Anne-Wil HARZING * 1. Introduction Since Hirsch s first publication of the h-index
More informationMoving from an IR to a CRIS, the why & how. Coalition for Networked Information Spring 2013 Membership Meeting, San Antonio, 4-5 April 2013
Title Moving from an IR to a CRIS, the why & how Author(s) Palmer, DT Citation Coalition for Networked Information Spring 2013 Membership Meeting, San Antonio, 4-5 April 2013 Issued Date 2013 URL http://hdl.handle.net/10722/181895
More informationJOURNAL RANKING 2014 FOR BIOCHEMICAL RESEARCH METHODS
The data source used is Journal Citation Reports (JCR) published by Thomson Reuters. Data generated from JCR Science Edition 2014. Biochemical Research Methods includes resources that describe specific
More informationUnicyte AG, regenerative medicine unit of Fresenius Medical Care, appoints world-leading experts to Scientific Advisory Board
Press Release Media Contact Martin Kunze T +49 6172 609-2115 martin.kunze@fresenius.com Contact for analysts and investors Dr. Dominik Heger T +49 6172 609-2601 dominik.heger@fmc-ag.com July 25, 2017 www.freseniusmedicalcare.com
More informationGetting Your Paper Noticed
Getting Your Paper Noticed The tools available to you Nicholas Pak, Solutions Consultant October 2015 2 You want to make sure your article gets the attention it deserves The volume of research articles
More informationIntroduction to Adaptive Design Roger J. Lewis, MD, PhD
Introduction to Adaptive Design Roger J. Lewis, MD, PhD Financial Disclosures Berry Consultants, LLC Multiple clients U01 Support from National Institutes of Health/NINDS Food and Drug Administration AspenBio
More informationICISSP 2020, 6th Int. Conf. on Information Systems Security and Privacy
ICISSP 2020, 6th Int. Conf. on Information Systems Security and Privacy SCOPE The International Conference on Information Systems Security and Privacy aims at creating a meeting point for researchers and
More informationA Review on Microdosing: Reduction in Cost & Time
Human Journals Review Article June 2016 Vol.:6, Issue:3 All rights are reserved by Rupali Yevale et al. A Review on Microdosing: Reduction in Cost & Time Keywords: Microdosing, phase 0, LC-MS and AMS ABSTRACT
More informationPage 78
A Case Study for Radiation Therapy Dose Finding Utilizing Bayesian Sequential Trial Design Author s Details: (1) Fuyu Song and (2)(3) Shein-Chung Chow 1 Peking University Clinical Research Institute, Peking
More informationPHOTOPTICS 2020, 8th Int. Conf. on Photonics, Optics and Laser Technology
PHOTOPTICS 2020, 8th Int. Conf. on Photonics, Optics and Laser Technology SCOPE Optics has a long and distinct tradition among physical sciences. Ever-present throughout human history, optical systems
More informationHYPOTHETICAL SCENARIO: MINI SUMMIT II: R&D COMPLIANCE
HYPOTHETICAL SCENARIO: MINI SUMMIT II: R&D COMPLIANCE Dan Kracov, Arnold & Porter (Moderator) Sue Seferian, Johnson & Johnson Natasha Leskovsek, Cooley Michelle Shwery, Eli Lilly Pharmaceutical and Medical
More informationGood Practice in Traditional Chinese Medicine Research in the Post-genomic Era GP-TCM D5.9
Good Practice in Traditional Chinese Medicine Research in the Post-genomic Era GP-TCM 223154 D5.9 Recommendations on the application of functional genomic studies and chemical synthesis to the study of
More informationOverview and Status Update
T H E S C R I P P S R E S E A R C H I N S T I T U T E S C R I P P S F L O R I D A T H E S C R I P P S R E S E A R C H I N S T I T U T E Scripps Florida Overview and Status Update 7 November 2011 Harry
More informationJournal metrics. Liz Wager PhD. Sideview. On behalf of CACTUS. Measuring journal performance: You can measure. Outcomes. Process. Sideview.
Journal metrics Liz Wager PhD Sideview On behalf of CACTUS Measuring journal performance: You can measure Outcomes Process Sideview What aspect do you want to measure? Profitability Reporting quality Speed
More informationModeling & simulation in pediatric drug development and regulation
EMEA, Workshop on Modelling in Paediatric Medicines London, April 14-15, 2008 Modeling & simulation in pediatric drug development and regulation Carl Peck, MD UCSF Center for Drug Development Science UC-Washington
More informationHST MEMP TQE Concentration Areas ~ Approved Subjects Grid
HST MEMP TQE Concentration Areas ~ Approved Subjects Grid Aeronautics and Astronautics Biological Engineering Brain and Cognitive Sciences Chemical Engineering 2.080J; 2.183J; choose BOTH choose ONE choose
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 08,000.7 M Open access books available International authors and editors Downloads Our authors
More informationCTTI Overview One Decade of Impact. One Vision Ahead.
Feb. 6, 2018 CTTI Overview One Decade of Impact. One Vision Ahead. Pamela Tenaerts, MD, MBA Executive Director #CelebrateCTTI Discover how CTTI has influenced the clinical trials enterprise during the
More information8/3/2016. Jatinder R Palta PhD Virginia Commonwealth University and National Radiation Oncology Program Veterans Health Affairs Richmond, Virginia
Jatinder R Palta PhD Virginia Commonwealth University and National Radiation Oncology Program Veterans Health Affairs Richmond, Virginia Virtual simulation, 3D computation & optimization, IMRT, IGRT, MC
More informationAn Analysis of the Achievements of JST Operations through Scientific Patenting: Linkage Between Patents and Scientific Papers
An Analysis of the Achievements of JST Operations through Scientific Patenting: Linkage Between Patents and Scientific Papers Mari Jibu Abstract Scientific Patenting, the linkage between patents and scientific
More informationDoes it matter which citation tool is used to compare the h-index of a group of highly cited researchers?
Author manuscript, published in "Australian Journal of Basic and Applied Sciences 7, 4 (2013) 198-202" Does it matter which citation tool is used to compare the h-index of a group of highly cited researchers?
More informationUnderstanding the FDA Guidance on Adaptive Designs: Historical, Legal and Statistical Perspectives
Understanding the FDA Guidance on Adaptive Designs: Historical, Legal and Statistical Perspectives Copyright c Qing Liu, Ph.D. qliu2@its.jnj.com Statistical Science Janssen R&D of Johnson & Johnson BASS
More informationGPU-accelerated Model-Based Drug Development. Chee M Ng, Pharm.D., Ph.D., FCP
GPU-accelerated Model-Based Drug Development Chee M Ng, Pharm.D., Ph.D., FCP Outlines What is model-based drug development Nonlinear Mixed-effect Model (NLME) for model-based drug development approach
More informationCOMPUTER AIDED DRUG DESIGN: AN OVERVIEW
Available online on 19.09.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-18, publisher and licensee JDDT, This is an Open
More informationAcceptance of Foreign Clinical Data A U.S. Perspective
Acceptance of Foreign Clinical Data A U.S. Perspective Robert L. Justice, M.D., M.S. 9 th Kitasato University Harvard School of Public Health Symposium Disclaimer The views expressed in this presentation
More informationThe MESUR Project In Search of Usage-Based Metrics of Scholarly Impact
The MESUR Project In Search of Usage-Based Metrics of Scholarly Impact http://www.mesur.org Johan Bollen (1) and Herbert van de Sompel (2) Los Alamos National Laboratory - Research Library (1) jbollen@lanl.gov
More informationReview of Biomedical Image Processing
BOOK REVIEW Open Access Review of Biomedical Image Processing Edward J Ciaccio Correspondence: ciaccio@columbia. edu Department of Medicine, Columbia University, New York, USA Abstract This article is
More informationIntroduction to Pharmacogenomics
Introduction to Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Overview of the lecture Overview of the lecture Introduction
More informationTracking and measuring your research impact: A guide to using metrics and altmetrics.
Tracking and measuring your research impact: A guide to using metrics and altmetrics. Jane Haigh Subject Librarian, Edinburgh Napier University. This session will provide an overview of some of the most
More informationA bold vision for 2025
Leading the Biomedical Revolution in Precision Health: How Stanford Medicine is Developing the Next Generation of Health Annual Stanford Medicine Population Health Sciences Colloquium October 26, 2015
More informationInternational Conference on Biochemistry, Genetics & Molecular Research Theme: An Evolving Science of Life
International Conference on Biochemistry, Genetics & Molecular Research Theme: An Evolving Science of Life About the Conference: Gavin Conferences invites participants from all over the world to attend
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationIntroduction to Drug Design and Discovery
Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,
More informationOMICS Journals are welcoming Submissions
OMICS Journals are welcoming Submissions OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible
More informationShort Course: Adaptive Clinical Trials
Short Course: Adaptive Clinical Trials Presented at the 2 Annual Meeting of the Society for Clinical Trials Vancouver, Canada Roger J. Lewis, MD, PhD Department of Emergency Medicine Harbor-UCLA Medical
More informationTowards a Broader Understanding of Journal Impact: Measuring Relationships between Journal Characteristics and Scholarly Impact
Towards a Broader Understanding of Journal Impact: Measuring Relationships between Journal Characteristics and Scholarly Impact X. Gu, K. L. Blackmore 1 Abstract The impact factor was introduced to measure
More informationBIOSTATISTICS AND MEDICAL INFORMATICS (B M I)
Biostatistics and Medical Informatics (B M I) 1 BIOSTATISTICS AND MEDICAL INFORMATICS (B M I) B M I/POP HLTH 451 INTRODUCTION TO SAS PROGRAMMING FOR 2 credits. Use of the SAS programming language for the
More informationSynthetic Viruses Targeting Cancer
Synthetic Viruses Targeting Cancer Andrew Hessel September 7, 2007 SENS 3, Cambridge, UK Why is a new strategy necessary? Breast cancer remains a significant cause of illness and death The treatment options
More informationWho is Pressing for Metrics on Scholarly Output?
Who is Pressing for Metrics on Scholarly Output? Workshop on Rankings in Social Sciences and Humanities University of Ottawa, September 24, 2013 Ian D. Clark (www.ian-clark.ca) School of Public Policy
More informationInternational Conference on Engineering Technology & Applied Sciences Theme: Discovery, Invention & Innovation of Technology
International Conference on Engineering Technology & Applied Sciences Theme: Discovery, Invention & Innovation of Technology About the Conference: Gavin Conferences invites participants from all over the
More informationPredicting DILI: An Inside the Box Analysis. Thomas W. Jones, Ph.D. Chief Scientific Officer, Toxicology & Pathology Eli Lilly and Company
Predicting DILI: An Inside the Box Analysis Thomas W. Jones, Ph.D. Chief Scientific Officer, Toxicology & Pathology Eli Lilly and Company Defining The Scale Of The DILI Problem NCE Candidates (%) Preclinical
More informationBioinformatics And Computational Biology In Drug Discovery And Development
Bioinformatics And Computational Biology In Drug Discovery And Development We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing
More informationMonday, September 22, 2014 Kathy Renick and Scot Erbe College of Public Health s Office of Research
Monday, September 22, 2014 Kathy Renick and Scot Erbe College of Public Health s Office of Research Ensures that the public has access to the results of NIH-funded research Requires scientists to submit
More informationLANGE BIOCHEMISTRY AND GENETICS FLASH CARDS 2 E LANGE FLASHCARDS
LANGE BIOCHEMISTRY AND GENETICS PDF MICHIEL LANGESLAG MEDICAL UNIVERSITY INNSBRUCK (PDF) BROOKER GENETICS ANALYSIS PRINCIPLES 4TH TXTBK 1 / 5 2 / 5 3 / 5 lange biochemistry and genetics pdf Michiel Langeslag,
More informationBIOMEDICAL ENGINEERING UNDERGRADUATE CURRICULUM
BIOMEDICAL ENGINEERING UNDERGRADUATE CURRICULUM 2012-2013 (as of 4/19/2012) includes the new Biology courses This program is accredited by the Engineering Accreditation Commission of ABET, http://www.abet.org.
More informationBiomedical Sciences Graduate Program
1 of 6 Graduate School 250 University Hall 230 North Oval Mall Columbus, OH 43210-1366 January 11, 2013 Phone (614) 292-6031 Fax (614) 292-3656 Jeff Parvin, Joanna Groden Co-Graduate Studies Chairs Biomedical
More informationIf you are searching for a book by Mitchel L. Zoler Stem cell transplantation may improve refractory SLE.(News)(systemic lupus erythematosus): An
Stem Cell Transplantation May Improve Refractory SLE.(News)(systemic Lupus Erythematosus): An Article From: Internal Medicine News [HTML] [Digital] By Mitchel L. Zoler READ ONLINE If you are searching
More informationDisciplinary Differences in Applying E-journal Usage Metrics. Mary Schoenborn Jim Stemper Katherine Chew Caroline Lilyard
Disciplinary Differences in Applying E-journal Usage Metrics Mary Schoenborn Jim Stemper Katherine Chew Caroline Lilyard Inspirations Deborah Helman, UW-Madison: Cancellation Criteria for Eng. Faculty
More information395 South Youngs Road Buffalo, New York cognigencorp.com An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise
395 South Youngs Road Buffalo, New York 14221 716.633.3463 cognigencorp.com An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise A Workshop For Improving the Efficiency and Effectiveness
More informationGrover L. Waldrop From the Division of Biochemistry and Molecular Biology, Louisiana State University, Baton Rouge, Louisiana 70803
Q 2009 by The International Union of Biochemistry and Molecular Biology BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION Vol. 37, No. 1, pp. 11 15, 2009 Articles A Qualitative Approach to Enzyme Inhibition
More informationContinuous, Dynamic and Comprehensive Article-Level Evaluation of Scientific Literature
Continuous, Dynamic and Comprehensive Article-Level Evaluation of Scientific Literature Xianwen Wang*, Zhichao Fang and Yang Yang WISE Lab, School of Public Administration & Law, Dalian University of Technology,
More informationStem Cell Research: Identifying emerging high priority policy issues
The state stem cell agency Stem Cell Research: Identifying emerging high priority policy issues Ellen G. Feigal, M.D. SVP, Research and Development National Cancer Policy Summit Washington, DC November
More informationFUTURE MEANS CREATIVITY
START-UP & ACADEMICS THEORY & PRACTICE IN DRUG DEVELOPMENT 1 EARLY PHASE DRUG DEVELOPMENT COURSE MAY 9 TH 2017 - ANTWERP FUTURE MEANS CREATIVITY VENUE: LINDNER HOTEL LANGE KIEVITSTRAAT 125 BE-2018 ANTWERP,
More informationFACULTY ACTIVITY INFORMATION REPORTING SYSTEM
FACULTY ACTIVITY INFORMATION REPORTING SYSTEM Presentation for University of Missouri - RFP # 14-9001-DH U August 29, 2013 AGENDA THOMSON REUTERS SOLUTION HELPS UM ADDRESS: FACULTY NEEDS ADMINISTRATOR
More informationQuality issues in biosimilars Some thoughts
Quality issues in biosimilars Some thoughts Norbert Benda Disclaimer: Views expressed in this presentation are the author's personal views and not necessarily the views of BfArM Statistical issues in quality
More informationInternational Comparative Performance of the Czech Republic Research base 2012
International Comparative Performance of the Czech Republic Research base 212 Prepared by Elsevier for the National Technical Library of the Czech Republic in October 212 SciVal Analytics executive summary
More informationResearch Progress and Prospects of Saudi Arabia
European Review for Medical and Pharmacological Sciences Research Progress and Prospects of Saudi Arabia in Global Medical Sciences S.A. MEO 1, A. HASSAN 2, A.M. USMANI 2 2013; 17: 3265-3271 1 Department
More informationFuture of Pharmaceutical Quality and the Path to Get There
Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research 3rd PQRI/FDA Conference on Advancing
More informationSCOAP3: where libraries, scientists and publishers meet repositories, peer-reviewed journals and Open Access.
CERN-OPEN-2009-011 July 14 th, 2009 SCOAP3: where libraries, scientists and publishers meet repositories, peer-reviewed journals and Open Access. Salvatore Mele CERN, European Organization for Nuclear
More informationData standardization and advancing regulatory science
Data standardization and advancing regulatory science Yoshiaki Uyama, Ph.D. Pharmaceuticals & Medical Devices Agency (PMDA) Visiting Professor, Graduate School of Medicine, Chiba University Visiting Professor,
More informationInvesting in Discovery
Investing in Discovery The Impact of Basic Research and the Role of the National Institute of General Medical Sciences Jeremy M. Berg, Ph.D. Director National Institute of General Medical Sciences National
More informationSummary. Science - Communication - Innovation Management - Clinical Investigation
Summary Knowledge Transfer Pathways from Research to Patient Treatment Science - Communication - Innovation Management - Clinical Investigation International Workshop on September 28, 2018 at House of
More informationMOLECULAR BIOLOGY OF THE CELL ALBERTS 6TH EDITION FREE
page 1 / 5 page 2 / 5 molecular biology of the pdf Journal Impact Factor: 1.48. ISSN: 2471-8084. Biochemistry and Molecular Biology Journal is an international scholarly, peer reviewed journal presenting
More informationTruth Telling and Suppressed Drug Research Data. Science and the pursuit of truth
Truth Telling and Suppressed Drug Research Data Erick H. Turner, M.D. Senior Scholar, OHSU Center for Ethics in Health Care Assistant Professor, OHSU Dept. of Psychiatry Assistant Professor, OHSU Dept.
More informationSupporting Information
Supporting Information igh-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells Lesley A. Mathews Griner 1,
More informationREPORT ON 2 nd BWC. 6. Regenerative Medicine: stem cells, gene therapy; tissue engineering; cell based therapy; cell cultivation.
REPORT ON 2 nd BWC INTRODUCTION The Biotechnology World Congress marked the initiation of the first of its series in February 2013 in Dubai. With the overwhelming success of 1 st BWC, the organizers, Eureka
More informationWhy do clinicians love 3+3? How do we help them de-love it? How to properly model late onset toxicity?
Why do clinicians love 3+3? How do we help them de-love it? How to properly model late onset toxicity? How to use big data in drug development and dose selection? How to design combination dose-finding
More informationFeature Selection of Gene Expression Data for Cancer Classification: A Review
Available online at www.sciencedirect.com ScienceDirect Procedia Computer Science 50 (2015 ) 52 57 2nd International Symposium on Big Data and Cloud Computing (ISBCC 15) Feature Selection of Gene Expression
More informationScientometrics and the Digital Existence of Scientist(s): Methodology, Myth(s) & Reality
Scientometrics and the Digital Existence of Scientist(s): Methodology, Myth(s) & Reality Vijay Kothari Ph.D. Ahmedabad vijay.kothari@nirmauni.ac.in vijay23112004@yahoo.co.in State Level Symposium at SRKI
More informationChun Wu Research Assistant Professor University of California Santa Barbara
Accurate bio-molecule model(force field) + China super computer: upgrade China s bio-research, pharmaceutical & bio-tech industries using molecular dynamics simulation Chun Wu Research Assistant Professor
More informationFood & Drug Administration Amendments Act of 2007
Food & Drug Administration Amendments Act of 2007 Implications for Public Planning Professionals and for Bio-Medical Publication Larry Hirsch, MD President, ISMPP January 17, 2008 Outline ISMPP What, Who,
More informationSystems Biology for Cancer Drug Development. Dr. Christophe Chassagnole, COO
Systems Biology for Cancer Drug Development Dr. Christophe Chassagnole, COO Copyright Physiomics plc 2008 1 Disclaimer With the exception of historical information, certain matters discussed in this presentation
More informationa thousand smiles. in one celebration. Life.
a thousand smiles. in one celebration. a thousand milestones. in one journey. Established in 1953, Biological E Limited (BE) is a leading, world-class Pharmaceutical and Biologics company with an impressive
More informationInvestigational New Drug Application
Investigational New Drug Application Regulatory Sponsor: Funding Sponsor: Study Product: Protocol Number: Name of the Sponsor-Investigator Department Name Address Phone Number Name of Primary Funding Institution
More informationOncology Product and Platform Partnering Opportunity
Protein Medicinal Chemistry with an Expanded Genetic Code Oncology Product and Platform Partnering Opportunity April 2017 Ambrx has Made Advances in Proprietary Platform and Titer while Achieving Clinical
More informationHigh Profile Publishing in Molecular Biology. Hélène Hodak, Marina Ostankovitch,
High Profile Publishing in Molecular Biology Hélène Hodak, h.hodak@elsevier.com Marina Ostankovitch, m.ostankovitch@elsevier.com The field of Molecular Biology, inception to current trends Preparing a
More informationApplying Affimers. Dr Amanda Nicholl at Avacta Life Sciences. Improving Antibody PK Assay Development
Improving Pharmacokinetic Assays in a Regulatory Bioanalysis Setting Applying Affimers With an increasing number of antibody-based therapeutics entering the clinic, the need for validated anti-idiotypic
More informationTable of Contents The School of Biomedical Engineering, Science and Health Systems: Undergraduate Programs
Table of The School of Biomedical Engineering, Science and Health Systems: Undergraduate Programs About the School...2 Undergraduate Major Biomedical Engineering...4 About the Major Concentrations Biomaterials
More informationThe Weizmann Institute of Science. Discovering Basic Science
The Weizmann Institute of Science Discovering Basic Science 1 THE WEIZMANN INSTITUTE OF SCIENCE FOCUSED ON RESEARCH 260 400 850 1000 Professors Heading research groups Administrative staff Scientists Ph.D.
More informationFor immediate release
For immediate release Livazo (pitavastatin), a new potent statin with beneficial effects on lipid fractions associated with heart disease, launches in Spain Wokingham, UK, 3 May 2011: Kowa Pharmaceutical
More informationFNIH: NASH Biomarker Consortium. Presenter: Roberto Calle on behalf of Foundation for the National Institutes of Health
FNIH: NASH Biomarker Consortium Presenter: Roberto Calle on behalf of Foundation for the National Institutes of Health LIVER FORUM Development of Non-invasive Biomarkers for Non-alcoholic Steatohepatitis
More informationMake your research visible! Luleå University Library
Make your research visible! Luleå University Library Why this guide? Maximizing the visibility and impact of research is becoming ever more important in the academic world with tougher competition and
More informationPharmacogenomics Relating to Drug Evaluation
Pharmacogenomics Relating to Drug Evaluation Yoshiaki Uyama,, Ph.D. Office of New Drug III (PMDA) Recent Topics relating to PGx Tarceva (erlotinib) Approved by FDA in Nov 2004 for NSCLC Randomized, Double-Blind,
More informationDisciplinary Differences in Applying E-Journal Usage Metrics
City University of New York (CUNY) CUNY Academic Works CUNY Library Assessment Conference Conference Proceedings 6-6-2014 Disciplinary Differences in Applying E-Journal Usage Metrics Katherine Chew University
More informationMCRA Clinical More Than Your Average CRO. Clinical Project Management. Site Management and Study Monitoring. Data Management. Auxiliary Services
MCRA s unique Clinical Research Organization (CRO) enables international and US-based orthopedic companies of all sizes to successfully execute a clinical study. Our philosophy is to streamline the clinical
More information